HOYA Vision Care, a leader in optical technology innovation, took part in the 4th World Congress of Optometry (WCO4) on 8–10 September 2023 in Melbourne, Australia. This year’s WCO4, hosted in partnership with O=MEGA23, was a prime opportunity for Eye Care Professionals from across the globe to participate in high quality learning and professional development.
As a proud Diamond sponsor of the WCO, and part of its commitment to share scientific knowledge and professional insights, HOYA Vision Care hosted a symposium “Lighting the way: new evidence and advances in myopia management”, where leading experts shared recent research findings in the childhood myopia management space. The symposium was chaired by Dr. Jagrut Lallu, Optometrist from Hamilton, New Zealand.
Previous studies conducted by Professor Carly Lam and her team demonstrated the benefits of MiYOSMART spectacle lenses use in children living in Hong Kong.1 HOYA Vision Care conducted research to explore whether the results translated to children living in Europe. Professor Kathryn Saunders presented the outcomes from a recent 12-month observational study conducted in the UK, which showed that MiYOSMART spectacle lenses significantly reduced myopia progression and axial elongation in UK children, and concluded that the changes in spherical refractive error and axial length growth in European children were comparable with those in Asian children.2
With continuing interest and emerging evidence about protective effects of outdoor time and daylight on myopia progression in children,3–7 Dr. May Zhang, Global Head of Professional Affairs at HOYA Vision Care, educated the audience on the researched benefits and risks associated with light exposure on myopic eyes and introduced the new MiYOSMART Chameleon and MiYOSMART Sunbird sun spectacle lenses, which provide protection from intense sunlight, while simultaneously slowing down myopia progression using D.I.M.S. Technology.8–14 Dr. Zhang also shared the early experience with MiYOSMART sun solutions, which showed at its early stage that almost 80% of children adapted to the new spectacle lenses within a few hours.
At the end of the symposium, Dr. Soojin Nam, Optometrist from Hillsdale, Australia, spoke about MiYOSMART solutions in clinical practice and shared case studies from her vast experience in the field of myopia management, showing that every patient has unique visual needs that could be addressed with customized treatment.
New evidence was also presented in the plenary program and in the posters’ session. Dr. Jagrut Lallu had presented the effectiveness of MiYOSMART and related combination treatment strategy in slowing down myopia progression among multi-ethnic patients in New Zealand.15 Dr. Joanna Przeździecka-Dołyk presented the outcomes of myopia controlling procedures in young adults with early-onset progressive myopia in regard to the refractive or axial main course of the refraction error, which showed better results in slowing axial elongation using optical methods, rather than pharmacological interventions.16 To conclude, Dr. Oliver Woo presented real-world evidence on the use of MiYOSMART spectacle lenses in Australian children of Chinese descent, showing yet another instance of satisfactory treatment and myopia slowing effect.17
Since its launch in 2018 through the end of 2022, over four million MiYOSMART spectacle lenses have been purchased by parents across the world.18 With the launch of the new MiYOSMART Chameleon and MiYOSMART Sunbird spectacle lenses, HOYA Vision Care will continue to help fight and control the growing problem of myopia around the world.
Product Disclaimer: MiYOSMART spectacle lenses have not been approved for use in the management of Myopia in all countries, including the U.S., and are not currently available for sale in all countries, including the U.S.
About HOYA Vision Care
For over 60 years, HOYA Vision Care has been a passionate and global leader in optical technology innovation. As a manufacturer of high-quality, high-performing eyeglass lenses, HOYA continuously aims to bring the best possible vision care solutions to Eye Care Professionals and their patients around the world. The company supplies lenses in 110 countries with a network of over 17,000 employees and 43 laboratories around the globe.
For further information please contact:
HOYA Vision Care PR
Name: Susan Brown
Follow HOYA Vision Care on Linkedin
- Lam CSY, Tang WC, Tse DY, et al. Defocus Incorporated Multiple Segments (DIMS) spectacle lenses slow myopia progression: a 2-year randomised clinical trial. Br J Ophthalmol. 2020;104(3):363-368.
- McCullough S, Barr, H, Fulton, J, et al. MiYOSMART myopia control spectacle lenses in UK children: 12-month outcomes (Abstract). WCO 2023; 8-10 September 2023; Melbourne, Australia.
- Jonas JB, Ang M, Cho P, et al. IMI prevention of myopia and its progression. Invest Ophthalmol Vis Sci. 2021;62(5):6.
- Ho CL, Wu WF, Liou YM. Dose-Response Relationship of Outdoor Exposure and Myopia Indicators: A Systematic Review and Meta-Analysis of Various Research Methods. Int J Environ Res Public Health. 2019;16(14):2595.
- Xiong S, Sankaridurg P, Naduvilath T, et al. Time spent in outdoor activities in relation to myopia prevention and control: a meta-analysis and systematic review. Acta Ophthalmol. 2017;95(6):551-566.
- Dhakal R, Shah R, Huntjens B, et al. Time spent outdoors as an intervention for myopia prevention and control in children: an overview of systematic reviews. Ophthalmic Physiol Opt. 2022;42(3):545-558.
- Karthikeyan SK, Ashwini DL, Priyanka M, et al. Physical activity, time spent outdoors, and near work in relation to myopia prevalence, incidence, and progression: An overview of systematic reviews and meta-analyses. Indian J Ophthalmol. 2022;70(3):728-739.
- HOYA data on file. Transmission, traffic light recognition, and UV blocking test for MiYOSMART clear and polarized lenses. 02/2023. Tests were conducted at room temperature (23°C).
- HOYA data on file. PSF test on MiYOSMART clear and sun spectacle lenses. 06/2022.
- Lakkis C, Weidemann K. Evaluation of the performance of photochromic spectacle lenses in children and adolescents aged 10 to 15 years. Clin Exp Optom. 2006;89(4):246-252.
- Renzi-Hammond LM, Hammond BR Jr. The effects of photochromic lenses on visual performance. Clin Exp Optom. 2016;99(6):568-574.
- Wu PC, Kuo HK. Effect of photochromic spectacles on visual symptoms and contrast sensitivity of myopic schoolchildren treated with low dose concentration atropine. Invest Ophthalmol Vis Sci. 2016;57:2484. Available at:
https://iovs.arvojournals.org/article.aspx?articleid=2560920 (Last accessed 01/06/2023).
- WSPOS. Sunlight Exposure & Children’s Eyes Consensus Statement. 2016. Available at: https://www.wspos.org/wspos-sunlight-exposure-childrens-eyes-consensus statement/ (Last accessed 01/06/2023).
- Quintana MS, Langa A, del Moral-Martinez I, et al. Polarized Filters Enhance Contrast Sensitivity When Glare Is Produced On A Flat Surface Under Photopic Conditions. Invest Ophthalmol Vis Sci. 2006;47(13):1225.
- Lallu J. Miyosmart And Combination Treatments In Myopia Management (Abstract). WCO 2023; 8-10 September 2023; Melbourne, Australia.
- Przeździecka-Dołyk J. Early-onset Progressive Myopia In Young Adults And Its Responsiveness Towards Myopia-controlling Modalities (Abstract). WCO 2023; 8-10 September 2023; Melbourne, Australia.
- Woo O. Effectiveness of Defocus Incorporated Multiple Segments (DIMS) spectacle lenses: a retrospective real-world study in Asia-Australian population (Poster). WCO 2023; 8-10 September 2023; Melbourne, Australia.
- Based on number of MiYOSMART spectacle lenses sold per HOYA sales data on file as of June 2022.